## Abstract Copper‐catalysed addition of ethyl diazoacetate to methyl scearolate (20 mmol scale) and subsequent saponification gave 9, 10‐carboxymethylene, 9‐octadecenoic acid in 67% yield. The letter was decarbonylated by treatment with HClO~4~/Ac~2~O in the cold (76 μmol scale) to give cycloprope
Preparation of high-specific-activity d-[3-3H]pantothenic acid
✍ Scribed by David S. Vallari; Charles O. Rock
- Publisher
- Elsevier Science
- Year
- 1986
- Tongue
- English
- Weight
- 411 KB
- Volume
- 154
- Category
- Article
- ISSN
- 0003-2697
No coin nor oath required. For personal study only.
✦ Synopsis
High-specific-activity D-[3-3H]pantothenic acid (5 Ci/mmol) was prepared from commercially available beta-[3-3H]alanine employing Escherichia coli strain DV1 (panD2 pan F1). This strain is defective in beta-alanine synthesis and pantothenate uptake, and under appropriate growth conditions converted 85 to 90% of the input beta-[3-3H]alanine to extracellular D-[3-3H]pantothenate. The radiolabeled vitamin was purified from the medium by thin-layer chromatography followed by reverse-phase high-performance liquid chromatography. The overall yield of D-[3-3H]pantothenic acid was 30% and radiochemical purity was greater than 99%.
📜 SIMILAR VOLUMES
Isotopic exchange of hydrogen in a system of s~lvent-water-~H was used to prepare 5-Juoroorotic a ~i d -~H ( G ) which was decarboxylated and the hydrogen-3H removed from labile bonds to yield 5'-Juorouracil-6-3H. It was found in tracer experiments that a suitable solvent for the isotopic exchange o
## Abstract A selective total synthesis of [11,12‐^3^H]‐9‐__cis__‐retinoic acid 1 at a specific activity of 46 Ci/mmole is described. The alkyne 4, efficiently prepared in two steps from readily available starting materials, was partially reduced to 9,11‐di‐__cis__‐retinoic acid 3 with both deuteri
The preparation of the 61-specific ligand 7-benzylidenenaltrexone (BNTX), labeled with tritium at high specific activity (14.4 Ciimmol) was prepared in 33% yield and >98% purity by the aldol condensation of high specific activity [15,1 6-3H]naltrexone with benzaldehyde at high dilution.
Simple procedures for the preparation of UDP-D-[U-'\*C]galBCtUrOniC acid and UDP-D-[6+i]gatactose with high specific activities are described. The conversion involves the enzymatic oxidation of the appropriate UDP-o-galactose derivative to UDP-o-galactose-6aldehyde followed by either further oxidat